Eli Lilly CEO John Lechleiter isn't happy with new Massachusetts legislation governing the way drugmakers market their products to doctors: He's saying that the limits will hamper innovation and force companies to reconsider expanding in the state. Report [1]
Links:
[1] http://www.pharmalot.com/2008/09/lilly-ceo-to-boston-pharma-will-be-scared-away/